ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIRO..CY..TRBGCZEEHUPLSK..HRIS..MTNO........................*JDIM360 Ver 2.40 (30 Jan 2013) - 2999001/02132209CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120140416W173deBibliographieenBibliographyfrBibliographieEP08718797.7200803192009101920100224enenen895529 P20070319US2014041620141620091216200951201402122014072013051020140416201416C07D 473/18 20060101AFI20081007BHEP A61K 31/522 20060101ALI20081007BHEP A61P 37/00 20060101ALI20081007BHEP de9-SUBSTITUIERTE 8-OXOADENINVERBINDUNGEN ALS MODULATOREN DES TOLL-LIKE-REZEPTORS (TLR7)en9-SUBSTITUTED-8-OXO-ADENINE COMPOUNDS AS TOLL-LIKE RECEPTOR (TLR7 ) MODULATORSfrCOMPOSÉS 8-OXO-ADENINE 9 SUBSTITUÉ COMME MODULATEURS DU RÉCEPTEUR DE TYPE TOLL (TLR7)EP-A- 1 728 793WO-A1-2007/034881WO-A1-2007/034882WO-A1-2007/034916BONNERT, Roger, VictorAstraZeneca R & D Charnwood Bakewell RoadLoughborough Leicestershire LE11 5RHGBMCINALLY, ThomasAstraZeneca R & D Charnwood Bakewell RoadLoughborough Leicestershire LE11 5RHGBTHOM, StephenAstraZeneca R & D Charnwood Bakewell RoadLoughborough Leicestershire LE11 5RHGBAstraZeneca AB100826879102683-1X EP/RI151 85 SödertäljeSEDainippon Sumitomo Pharma Co., Ltd.100755295102683-1X EP/RI6-8, Dosho-machi 2-chome Chuo-ku Osaka-shiOsaka 541-8524JPCHDEESFRGBHRISITLILTLVMTNOPLSECurran, Sally Annet al101385563AstraZeneca Intellectual Property, Alderley ParkMacclesfield, Cheshire SK10 4TGGBATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMTNLNOPLPTROSESISKTRGB200800095820080319enWO20081140082008092520083920091216200951